Brian Harmon
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- Phagocytosis and Immune Regulation
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Molecular Biology top 2%
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
Papers in
-
- Cell death mechanisms and regulation 17
- RNA Interference and Gene Delivery 8
- Cancer therapeutics and mechanisms 3
-
- Phagocytosis and Immune Regulation 3
- Co-authors
- J. F. R. Kerr (13 shared papers)Clay Winterford (4 shared papers)Glenda C. Gobé (8 shared papers)Russell J. Collins (5 shared papers)J. Searle (4 shared papers)David J. Allan (6 shared papers)John W. Sedat (2 shared papers)G. Gobe (1 shared paper)
- Journals
- The Journal of Pathology (7 papers)International Journal of Radiation Biology (3 papers)Cell Proliferation (2 papers)Pathology (2 papers)Cancer (1 paper)
- Partner nations
- AustraliaUnited StatesJapan
In The Last Decade
Brian Harmon
44 papers receiving 5.8k citations
Brian Harmon's Hit Papers
Peers
Comparison fields: 5 of 179
- Immunology 1.2k
- Molecular Biology 3.3k
- Oncology 1.2k
- Cancer Research 548
- Biotechnology 253
Countries citing papers authored by Brian Harmon
This map shows the geographic impact of Brian Harmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Harmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Harmon more than expected).
Fields of papers citing papers by Brian Harmon
This network shows the impact of papers produced by Brian Harmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Harmon. The network helps show where Brian Harmon may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Harmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Apoptosis. Its significance in cancer and cancer Therapy Hit paper breakdown → | 1994 | 1834 |
| 2 | 1995 | 421 | |
| 3 | 2001 | 410 | |
| 4 | 1992 | 404 | |
| 5 | Patterns of cell death. | 1988 | 401 |
| 6 | 1990 | 288 | |
| 7 | 1975 | 256 | |
| 8 | 1989 | 215 | |
| 9 | 1974 | 201 | |
| 10 | 1996 | 181 | |
| 11 | 1997 | 171 | |
| 12 | 1996 | 165 | |
| 13 | 1991 | 144 | |
| 14 | 1997 | 141 | |
| 15 | 1987 | 72 | |
| 16 | 2016 | 70 | |
| 17 | 1989 | 63 | |
| 18 | 2005 | 56 | |
| 19 | 1995 | 56 | |
| 20 | 1994 | 50 |
About Brian Harmon
Brian Harmon is a scholar working on Molecular Biology, Immunology, Surgery, Oncology and Epidemiology, having authored 44 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (17 papers), RNA Interference and Gene Delivery (8 papers), Diabetes and associated disorders (4 papers), Pancreatic function and diabetes (4 papers), Cancer-related Molecular Pathways (3 papers), Phagocytosis and Immune Regulation (3 papers), Cancer therapeutics and mechanisms (3 papers) and Diabetes Management and Research (2 papers). The work is most often cited by research in Immunology (1.2k citations), Molecular Biology (3.3k citations), Oncology (1.2k citations), Cancer Research (548 citations) and Biotechnology (253 citations). Brian Harmon has collaborated with scholars based in Australia, United States and Japan. Frequent co-authors include J. F. R. Kerr, Clay Winterford, Glenda C. Gobé, Russell J. Collins, J. Searle, David J. Allan, John W. Sedat, G. Gobe, Neal I. Walker and Bronwyn A. O’Brien. Their work appears in journals such as The Journal of Pathology, International Journal of Radiation Biology, Cell Proliferation, Pathology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.